Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ascentage, Cycle, Essa, Gan & Lee, Gannex, Kiadis, Mateon, Novartis, Pharmacyte, Regeneron, Reven, Sanofi, SK, Seneca, Supernus, Vaxart, Vertex, Ziopharm.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: ABL, Accord, Acelrx, Aimmune, Arctoris, Astrazeneca, Biogen, Daiichi Sankyo, Evotec, Glycot, Hifibio, J&J, Keros, Lava, Marinus, Medigen, Molecular Partners, Moleculin, Molteni, Navire, Navrogen, Nestle, Neuraxpharm, Orexo, Pascal, Pfizer, Reveragen, Santhera, Sorrento, S?rse, Springworks, Starpharma, Syntekabio Takeda, Talaris, Tikomed, Vaxess.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 89bio, AB Science, Actinium, Alexion, Alzprotect, Astrazeneca, Biontech, Blade, Boehringer, Caelum, Cassava, Celltrion, Cyxone, Daiichi, Diamedica, Diamyd, Enanta, Frequency, Humanigen, Immunity, Incyte, Inflarx, LB, Lilly, Myovant, Novartis, Pfizer, Pharmabcine, Regeneron.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Appili, Immupharma, Junshi, Seres, Sol-Gel.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amyris, Biocomo, Editas, Harbour, Hualan, Johnson & Johnson, Lavvan, Medicinova, VBL.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anavex, Aura, Atara, Bicycle, Biogen, Cancer Prevention, Celltrion, Clene, Galapagos, Genentech, GW, Immunic, Lilly, Lyra, Neurocrine, Novartis, Partner, Prothena, Reveragen, Santhera, Voyager.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Arch, Genmab, GSK, Halozyme, Sarepta, Terns, Zai Lab.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: ADC, Astrazeneca, Axon, Brink, Clinuvel, Cmab, Cobra, Combigene, Fresenius Kabi, Gain, Generate, Havn, Immunomic, Immunoprecise, Kempharm, Know, KVK-Tech, Laekna, Ligand, Nabriva, Orion, Rockwell, Sumitomo Dainippon, Totient.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anavex, Arbor, Astrazeneca, Avillion, Bayer, Biohaven, Boehringer Ingelheim, Corcept, Corvus, Diffusion, Forte, Gemini, Haliodx, Histogen, Imcheck, Ocular, Recce, Roche, Sanofi, Satsuma, Seneca, Sobi, Sutro, Takeda, Theratechnologies, VBL, Vertex, Zogenix.